Peter Schmieder

Dr. Peter Schmieder serves as Head of the NMR Facility at the Leibniz Research Institute for Molecular Pharmacology (FMP) in Berlin-Buch, Germany. He is responsible for the operation, maintenance, and strategic development of the institute’s NMR infrastructure, which includes multiple high-field spectrometers used for both solution and solid-state spectroscopy. In addition to his scientific role, he is actively involved in the works council (Betriebsrat) at FMP.

Research Interests:

• NMR spectroscopy for structural and dynamic studies of biomolecules
• Development and application of solid-state NMR for membrane proteins and protein aggregates
• Dynamic nuclear polarization (DNP) techniques
• Phosphorylation analysis via 31P NMR
• Collaborative projects in chemical biology and structural biology

Dr. Schmieder leads the Determination of pKa values by NMR project, in collaboration with researchers such as Anett Hauser, Lisa Gerland, Christian Hackenberger, and Hartmut Oschkinat. His team provides both routine and advanced NMR services to internal and external users, including academic institutions and industry partners.

The NMR Facility hosts a wide range of Bruker spectrometers, including 300 MHz, 600 MHz, 750 MHz, and 900 MHz systems, equipped with cryoprobes, solid-state probes, and DNP capabilities. The facility is part of the DFG-funded G-NMR network and the EU iNEXT infrastructure initiative, reinforcing its role in national and European research collaborations.